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The declining HIV seroprevalence
in Uganda: what evidence?
Joseph K. Konde-Lule
Institute of Public Health, Makerere University, Kampala
Papers presented at the ninth International Conference on AIDS and STDs in Africa, held at
Kampala in December 1995, show that HIV prevalence has apparently been on a downward
trend in several sectors of the population of Uganda over the past few years. This article
reviews the relevant presentations.
Background
Uganda is a landlocked country in East Africa astride the equator with a population of about
18 million people increasing at an annual rate of 2.5 per cent. The country is divided into 39
administrative districts, each with an average population of about half a million. The
population structure is similar to that of other countries in the region where half the
population is below 16 years old. Uganda is one of the countries in Africa where AIDS was
recognized as a public health problem relatively early, in the mid-1980s. HIV seroprevalence
among pregnant women in the capital city, Kampala, was found to be about 15 per cent in
1986 when HIV screening was first done. The prevalence levels rose steadily until 1989-1990
when levels in various prenatal clinics in Kampala city stabilized between 25 and 30 per cent.
Reports of falling HIV prevalence rates in 1995 were therefore received as very good news in
a society where virtually everyone has in some way been affected by the epidemic and where
health workers, public leaders and the general public have all been severely demoralized by
the epidemic.
Sources of available evidence
The downward trend in HIV seroprevalence was reported from the following sources: studies
of HIV among pregnant women in Mulago hospital, which is the main referral hospital in
Kampala; sentinel surveillance data from antenatal clinics around the country; community-
based studies of HIV in Masaka and Rakai districts; and persons attending voluntary HIV
screening centres.
Studies among pregnant women in Mulago hospital, Kampala
Information on pregnant women in Mulago hospital is obtained from a presentation made by
the Human Reproduction Research Unit, Department of Obstetrics and Gynaecology,
Makerere University, Kampala (Bagenda et al. 1995). This paper had two sets of data. The
first data set showed HIV seroprevalence figures from persons attending various prenatal
clinics in Kampala during 1993, and demonstrated the variation of HIV infection rates by age
and other socio-demographic variables. The overall HIV prevalence among all women
attending eleven prenatal clinics in the city in 1993 was 20.5 per cent (95% CI 18%-23.1%).
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The second set of data was obtained from the Mulago hospital prenatal clinic alone and it
compared the 1993 HIV-1 prevalence figures with earlier, 1989 screening data from the same
clinic. The data show that during the 1989 screening HIV seroprevalence among pregnant
women attending this unit was 28.1 per cent (95% CI 26.6%-29.6%). In contrast, during
1993, the HIV seroprevalence among pregnant women attending the clinic was 16.2 per cent
(95% CI 12.2%-20.8%). The age distribution of HIV prevalence in 1993 was similar to that
in 1989, with pregnant women aged 20-22 years having the highest HIV prevalence rate.
Levels in 1989 and 1993 are shown in Table 1.
Table 1
HIV-1 prevalence among pregnant women attending Mulago hospital prenatal clinic by age
group, 1989 and 1993
% HIV-positive (95% CI)
Age group 1989-90 1993
Less than 17 23.5 20.3-27.1 8.2 2.3-19.6
17-19 32.3 29.4-35.2 12.6 6.9-20.6
20-22 37.9 33.6-42.2 29.7 15.9-47.0
23-25 27.4 23.0-31.8 26.9 11.6-47.8
26-28 25.4 21.2-29.6 20.8 7.1-42.1
29-31 24.8 20.0-29.6 14.7 4.9-31.0
32-34 21.8 15.5-28.1 12.5 1.5-38.3
35-37 16.3 9.9-22.7 11.1 0.3-48.2
38+ 14.1 6.7-21.5 16.7 0.4-64.1
Total 28.1 26.6-29.6 16.2 12.2-20.8
There was a decline in HIV prevalence in all age groups except in persons aged 38 years
and above. The decline, however, was only statistically significant in the youngest age groups
below 17 and 17-19 years of age and in the overall rate. The presenters concluded that there
was a significant decline in the HIV prevalence rate of persons attending the Mulago hospital
prenatal clinic and that the biggest decline occurred in the youngest age groups.
Sentinel surveillance data
The HIV trends in sentinel surveillance sites were present in a paper from the STD/AIDS
control program of the Uganda Ministry of Health in collaboration with the WHO/GPA
(Asiimwe-Okiror et al. 1995). The team also provided the following background information
on sentinel surveillance in Uganda.
Sentinel surveillance for HIV was instituted by the Ministry of Health AIDS Control
Programme in 1989 with the aim of monitoring HIV prevalence trends in Uganda. In 1992 it
was observed that HIV prevalence rates at some urban sites were declining. In view of this
the surveillance unit planned an evaluation of the HIV sentinel surveillance system in 1994 to
determine whether the procedures used still adhered to the WHO protocol.
The evaluation showed that the procedures which were used in the surveillance system
were still in line with the recommended WHO protocol at all the sites. The results from all six
sites showed a statistically significant decline in HIV prevalence rates. HIV infection rates
between 1991 and 1994 at the sentinel surveillance sites which were evaluated are shown in
Table 2; there are 20 surveillance sites in the country but only six were evaluated.
The first two sites, Nsambya and Rubaga, are situated in different parts of Kampala city.
All sites show a declining trend in HIV prevalence rates between 1992 and 1994. The
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presenters concluded that the decline of HIV prevalence rates is real, although the rates are
still high.
Table 2
HIV infection rates (%) among pregnant women attending clinics at sentinel surveillance
sites in Uganda 1991-1994
HIV infection  rate (%)
Site 1991 1992 1993 1994
Nsambya 27.8 29.5 26.6 21.8
Rubaga 27.3 29.4 24.4 16.5
Mbarara 24.4 29.4 18.1 17.3
Jinja 22.0 19.9 16.7 16.3
Tororo 12.8 13.2 11.3 10.2
Mbale 12.0 14.8 8.7 10.2
Community-based study of HIV in Masaka district
Data from the Masaka cohort were presented by researchers from a collaboration of the
Medical Research Council (UK) program on AIDS in Uganda and the Uganda Virus
Research Institute (Kengeya-Kayondo et al. 1995). The presentation had details of the
dynamics of HIV-1 and associated mortality among adults. The study is conducted in a rural
area of Masaka district, in 15 neighbouring villages with a total population of about 10,000.
Since 1989 all consenting adults aged 13 years and over resident in the villages, about 4,000,
have been kept under surveillance through annual demographic and serological surveys.
Results
1. Overall adult HIV-1 seroprevalence rates have remained stable at about eight per cent
during the course of five annual screenings (rounds).
2. Prevalence rates in young men 13-24 years declined significantly with the figures from the
five rounds being 3.4, 3.6, 2.3, 1.6 and 1 per cent. The trend is significant (p<0.001).
3. Prevalence rates in young women 13-24 also declined but the trend was not significant.
The figures in the five rounds were 9.9, 8.2, 7.8, 8.1 and 7.3 per cent.
4. Incidence rates do not show a clear trend but are around 8 per 1,000 person-years. The
incidence figures in the periods between the five rounds are 8.1, 6.8, 6.0, 9.4 cases per 1,000
person-years.
5. Death rates overall, calculated per 1,000 person-years, show a rising trend in the four one-
year periods between the five rounds. The figures are 16.4, 19.5, 22.1 and 24.3 deaths per
1,000 person-years.
The researchers concluded that the decline in seroprevalence in young people is encouraging,
although there is little change in other indicators.
Community-based study in Rakai district
Data from the Rakai district cohort were presented by researchers from Rakai Project which
is a long-term collaboration between Makerere University (Uganda), Uganda Ministry of
Health, Columbia University (USA), Johns Hopkins University (USA) and the Uganda Virus
Research Institute in Entebbe, Uganda where the project is based (Serwadda et al. 1995).
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The purpose of the presentation was to assess the trends of HIV incidence and prevalence
in rural Rakai district, Uganda between 1990 and 1992. Data were obtained from 1945
households in 31 randomly selected clusters.
Results
1. Prevalence. Adult prevalence declined in the general cohort from 23.4 per cent to 20.9 per
cent between 1990 and 1992 (p<0.04). The decline was most pronounced in the main road
trading centres where prevalence fell from 37.8 per cent in 1990 to 31.1 per cent in 1992
(p<0.02). There was less change in trading villages (25.7% to 22.7%) and in rural villages
(13.6% to 13.1%), both not significant.
2. HIV incidence. Among persons 15-59 incidence declined in main road trading centres and
trading villages from 3.3 per 100 person-years of observation in 1990 to 2.1 per 100 in 1992;
but this was not significant. In agricultural villages incidence increased from 1.1 to 1.9 per
100 person-years (not significant).
3. Mortality. Mortality numbers of HIV-positive persons were higher than incidence
numbers in the two periods of follow-up, 1990-1991 and 1991-1992.
4. Persons 13-24 years old. In this age group, combining both sexes, prevalence declined
from 17.3 per cent in 1990 to 15.7 per cent in 1991 and to 12.6 per cent in 1992 (p<0.001).
The trends were similar in both sexes although prevalence was higher in females. Incidence
rates, however, remained constant in both sexes, being 1.4 per cent among males in both
follow-up years, while in females they were 3 per cent in the first and 3.1 per cent in the
second follow-up year. Significant declines in prevalence among the young are not associated
with any change in HIV incidence: serial prevalence measures may be misleading indicators.
Conclusions
HIV prevalence declined significantly in both open and closed cohorts in Rakai district; HIV
incidence did not decline in the cohort. Mortality among HIV-infected persons exceeded HIV
incidence in each follow-up year and influenced the observed secular decline of HIV
prevalence. Surveillance of the epidemic based on HIV prevalence figures alone can be
misleading in the absence of information on the balance between incidence, mortality,
migration and compliance.
Persons attending voluntary HIV testing in Uganda towns
Voluntary testing for HIV infection is conducted by a local private organization, the AIDS
Information Centre, which submitted no abstract or paper concerning HIV trends to the main
conference, but during the satellite meeting some data were presented from their records
(AIC 1995). The centre started to offer HIV screening services for a modest fee in Kampala
in 1990. Demand grew rapidly and three other branches were opened in provincial towns.
The people seeking the screening service commonly include those who suspect themselves to
be infected with HIV, or those planning to get married. The service is currently offered to
over 30,000 people every year.
The data presented showed HIV prevalence for all the persons screened in each year.
Beginning in 1990 the annual HIV prevalence rates for all persons who attended the
voluntary screening sites were 29, 28, 28 and 22 per cent, and 23 per cent in 1994. There was
a fall in HIV prevalence especially after 1992. The AIDS Information Centre shares its data
with any interested groups but goes to great lengths to explain that the data are not
generalizable to any other population since the persons who were screened are self-selected.
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The observed fall in HIV prevalence rates can be explained in many ways, including that
high-risk persons sought HIV screening earlier than others, and that more persons from rural
areas may be seeking HIV screening: their infection rates are known to be lower than those of
people from the towns.
Whereas the correct explanations probably include these and many others, it is notable
that there was a big drop in HIV prevalence after 1992, a trend which is not very different
from that observed in the other ‘properly’ designed studies. There was also a decline in HIV
seroprevalence among the youth aged 15-19 years. In this age group the prevalence figures
are available for three consecutive years beginning with 1992. Among males the prevalence
rate was 4.0 per cent in 1992, 3.2 per cent in 1993 and 3.1 per cent in 1994. Among females
the corresponding rates are 12, 12.2 and 10 per cent.
Discussion
All the five presentations under review report declining trends in HIV prevalence in the
populations which were studied. Two critical questions need to be answered: whether these
findings represent what is happening in the general population, and what the explanation is
for the downward trend in HIV seroprevalence. Of particular interest is whether the
downward trend is the result of a declining incidence rate of HIV which has in turn been
brought about by changes in behaviour.
Whereas most of the data presented come from urban areas, about 90 per cent of the
Uganda population live in rural areas. On the basis of the presentations which were made
during the conference it appears that the main factors which are affecting HIV seroprevalence
trends include HIV incidence, HIV-related mortality and demographic changes. The role of
each of these is now discussed in light of the available evidence.
Incidence
The very high prevalence rates observed in urban areas indicate that at some stage in the past,
HIV incidence rates must have been higher than those currently prevailing. The available
incidence figures were all measured at different times after 1990. Many workers in the field
agree that the current levels of incidence cannot sustain such high prevalence rates as are seen
in Kampala and other urban areas in Uganda. There is therefore some general consensus that
although HIV incidence levels must have declined, the main decline probably occurred before
the studies of HIV incidence. No one knows what the incidence rate in Kampala, Rakai or
any other part of Uganda was in the period 1985-1990. The community-based studies in
Masaka and Rakai show stable incidence rates in the period 1990-1993. If there has been any
big decline in incidence, then it is very likely to have predated this period.
The research team which presented the sentinel surveillance data worked on the
assumption that the downward trend in HIV sero-prevelance was the result of concurrently
declining incidence rates. They developed a model which attempted to explain the observed
seroprevalence trends in terms of reduced incidence rates. Unfortunately there has not been
any measure of HIV incidence in Kampala or in any of the sentinel surveillance sites which
would validate the assumption. If the incidence pattern which is reported from Rakai and
Masaka is generally similar to that which obtains in Kampala, or in the other areas where
sentinel sites are based, then we may have to search for another explanation of the falling
HIV seroprevalence levels than concurrently declining HIV incidence rates.
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Mortality
In the community-based studies which measured HIV incidence and HIV-related mortality, it
is quite clear that the numbers of HIV-positive persons dying each year far exceed the new
(incident) HIV infections during the same periods (Kengeya-Kayondo et al.; Serwadda et al.)
The researchers from the Rakai cohort felt that excess mortality among HIV-positive persons
could almost entirely explain the decline in HIV prevalence (Serwadda et al. 1995).
HIV-related mortality in Kampala or in any other urban areas in Uganda has not been
measured, but it is known to be quite high. The extent to which this is affecting HIV
seroprevalence is not known, but if findings from Masaka and Rakai are anything to go by,
then it is likely to be substantial. The HIV epidemic in Uganda started in urban areas and later
spread to rural areas, a process which is probably still continuing.
The districts of Masaka and Rakai are some of the few rural districts in Uganda where
HIV infection happened to spread fairly early. The epidemic in these two districts has
therefore ‘matured’. This is reflected in the high HIV-related mortality figures and stable or
declining HIV prevalence rates. In areas where HIV infection is newly introduced there is
very little HIV-related mortality and prevalence figures can only rise even when incidence
rates are very low. A ‘young’ HIV epidemic is little influenced by mortality, while a ‘mature’
one, which is the type of epidemic in many of the areas where the studies under review are
based, is heavily affected by mortality. At this stage, the HIV epidemic in most parts of
Uganda, including the rural areas, is becoming mature and the situation may be getting
generally similar to that in the study area.
Demographic transition
This term is used in reference to the continuous movement of young persons below 13 years
of age into the ‘adult’ category of persons 13 years old and above. Many studies have shown
that persons aged 5-15 years in the African region are essentially free of HIV infection, and
some workers have labelled this age group ‘window of hope’. If with time these people move
into the ‘adult’ category while retaining their HIV-negative status, then they could
conceivably be in a position to pull down the general HIV seroprevalence rate. This appears
to have happened in some parts of Uganda. During the period 1986-1990, persons in the age
group 15-24 were driving the epidemic, and many surveys showed that this age-group had the
highest HIV seroprevalence rates. This was particularly true for females. The individuals who
were in this age group have now moved into the older age groups. The younger people who
replaced them appear to have largely retained their HIV-negative status. This may be a major
factor in the decline of HIV prevalence. The drastic fall in HIV prevalence among those aged
13-24 has been reflected in all studies which have HIV infection rates by age (Bagenda et al.
1995; Kengeya-Kayondo et al. 1995; Serwadda et al. 1995; AIC  1995). In the Mulago
hospital data, the decline in seroprevalence among the youth below 20 years was the only
statistically significant age-specific decline.
The fall in HIV prevalence in persons aged 13-24 years probably reflects behaviour
change, and it may reflect the impact of the various intervention measures. The effect is
easier to demonstrate among young people in this age group because they join the adult group
when they are uninfected. Safe behaviour is therefore easily translated into remaining HIV-
negative. The older age groups may have had a change in behaviour but since they already
have high rates of HIV seroprevalence, behaviour changes among them take much longer to
be reflected in lower HIV seroprevalence rates.
HIV seroprevalence in the Mulago hospital prenatal clinic during 1993 was found to be
16.2 per cent, while the prevalence rate in all eleven clinics which were studied was 20.5 per
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cent. One of the possible explanations for the lower rate in Mulago hospital is that being a
referral hospital, Mulago gets many young pregnant women. Small units routinely refer first
pregnancies (primigravidae) to the hospital, and this gives the referral hospital a higher
proportion of pregnant women below 20 years old. The large numbers of these young
mothers probably pulled down the overall HIV seroprevalence at the unit. If this should be
the real explanation for the lower HIV prevalence rate in Mulago hospital when compared to
all the other prenatal clinics which were studied in the city, then the youth factor may be
playing a very significant role in the downward trend of HIV seroprevalence, not just in
Mulago hospital pregnant women, but in many other parts of the country. Both hospital-based
and community-based data appear to give this impression.
Conclusions
There appears to be a real decline in HIV seroprevalence in some population groups in
Uganda. The explanations are many and they vary between population groups. These include
a very high HIV-related mortality, demographic changes with many young persons joining
the adult category while retaining their HIV-negative status, and probably a lower HIV
incidence rate than that prevailing before 1990.
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